FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285800229> ?p ?o ?g. }

• W4285800229 abstract "Hu’po Anshen decoction (HPASD) is a traditional Chinese medicine formula comprising five herbal medicines for the treatment of concussion and fracture healing, but its pharmacological mechanism is still unclear. Ultra-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (UPLC/Q-TOF MS) was used to analyze the main active components of HPASD. Rats were randomly assigned to fracture group, fracture combined with traumatic brain injury (TBI) group (FBI) and FBI combined with HPASD treatment group (FBIH). Rats in the FBIH group were given oral doses of HPASD (2.4 g/kg, 4.8 g/kg and 9.6 g/kg) for 14 or 21 consecutive days. The fracture callus formation and fracture sites were determined by radiographic analysis and micron-scale computed tomography (micro-CT) analysis. Hematoxylin and eosin (H&amp;E) staining and a three-point bending test were applied to assess histological lesions and biomechanical properties, respectively. The levels of cytokines-/protein-related to bone formation and differentiation as well as PI3K/AKT pathway-related proteins were determined by Enzyme-linked immunosorbent assay (ELISA), quantitative reverse transcription-polymerase chain reaction (qRT-PCR), or western blot assays, respectively. UPLC-Q/TOF-MS-based serum metabolomic analysis was also performed to investigate the therapeutic effects of HPASD in the treatment of FBI. UPLC/Q-TOF MS analysis showed the chemical components in HPASD, including flavonoids, amino acids, saponins, and phenylpropanoid constituents, etc. HPASD dose-dependently promoted callus formation, increased bone density, improved mechanical parameters and morphological scores, and facilitated the expressions of VEGF, PDGF, bFGF, VEGFA, CoL1A1, RUNX2, BMP2, and Aggrecan, inhibited the expression of MMP13, and activated PI3K/AKT pathway. Metabolomics analysis revealed abnormalities of malate-aspartate shuttle and glucose-alanine. HPASD accelerates fracture healing by promoting bone formation and regulating the malate-aspartate shuttle and glucose-alanine cycle, which might be associated with the activation of the PI3K/AKT pathway." @default.
• W4285800229 created "2022-07-19" @default.
• W4285800229 creator A5017643380 @default.
• W4285800229 creator A5020651711 @default.
• W4285800229 creator A5044119010 @default.
• W4285800229 creator A5044936528 @default.
• W4285800229 creator A5070814895 @default.
• W4285800229 creator A5080907877 @default.
• W4285800229 creator A5084884716 @default.
• W4285800229 date "2022-07-18" @default.
• W4285800229 modified "2023-10-06" @default.
• W4285800229 title "Hu’po Anshen Decoction Accelerated Fracture-Healing in a Rat Model of Traumatic Brain Injury Through Activation of PI3K/AKT Pathway" @default.
• W4285800229 cites W1850507474 @default.
• W4285800229 cites W1996361385 @default.
• W4285800229 cites W2014368942 @default.
• W4285800229 cites W2028448521 @default.
• W4285800229 cites W2033323364 @default.
• W4285800229 cites W2035346822 @default.
• W4285800229 cites W2035969062 @default.
• W4285800229 cites W2090219806 @default.
• W4285800229 cites W2116864756 @default.
• W4285800229 cites W2121836743 @default.
• W4285800229 cites W2140908408 @default.
• W4285800229 cites W2159034171 @default.
• W4285800229 cites W2294632513 @default.
• W4285800229 cites W2338643722 @default.
• W4285800229 cites W2562818717 @default.
• W4285800229 cites W2591227149 @default.
• W4285800229 cites W2593848038 @default.
• W4285800229 cites W2623267344 @default.
• W4285800229 cites W2742952428 @default.
• W4285800229 cites W2751484191 @default.
• W4285800229 cites W2780787688 @default.
• W4285800229 cites W2783681765 @default.
• W4285800229 cites W2789054899 @default.
• W4285800229 cites W2803195573 @default.
• W4285800229 cites W2900506121 @default.
• W4285800229 cites W2904491888 @default.
• W4285800229 cites W2914319607 @default.
• W4285800229 cites W2968969690 @default.
• W4285800229 cites W2978543672 @default.
• W4285800229 cites W2982665975 @default.
• W4285800229 cites W2985596826 @default.
• W4285800229 cites W3008306433 @default.
• W4285800229 cites W3016358164 @default.
• W4285800229 cites W3037220801 @default.
• W4285800229 cites W3040770348 @default.
• W4285800229 cites W3084130987 @default.
• W4285800229 cites W3095043289 @default.
• W4285800229 cites W3104464025 @default.
• W4285800229 cites W3129796212 @default.
• W4285800229 cites W3131272701 @default.
• W4285800229 cites W3136338320 @default.
• W4285800229 cites W3173177706 @default.
• W4285800229 cites W3184868260 @default.
• W4285800229 cites W3201873895 @default.
• W4285800229 doi "https://doi.org/10.3389/fphar.2022.952696" @default.
• W4285800229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35924045" @default.
• W4285800229 hasPublicationYear "2022" @default.
• W4285800229 type Work @default.
• W4285800229 citedByCount "2" @default.
• W4285800229 countsByYear W42858002292023 @default.
• W4285800229 crossrefType "journal-article" @default.
• W4285800229 hasAuthorship W4285800229A5017643380 @default.
• W4285800229 hasAuthorship W4285800229A5020651711 @default.
• W4285800229 hasAuthorship W4285800229A5044119010 @default.
• W4285800229 hasAuthorship W4285800229A5044936528 @default.
• W4285800229 hasAuthorship W4285800229A5070814895 @default.
• W4285800229 hasAuthorship W4285800229A5080907877 @default.
• W4285800229 hasAuthorship W4285800229A5084884716 @default.
• W4285800229 hasBestOaLocation W42858002291 @default.
• W4285800229 hasConcept C104317684 @default.
• W4285800229 hasConcept C126322002 @default.
• W4285800229 hasConcept C141071460 @default.
• W4285800229 hasConcept C185592680 @default.
• W4285800229 hasConcept C190283241 @default.
• W4285800229 hasConcept C190409667 @default.
• W4285800229 hasConcept C2776415932 @default.
• W4285800229 hasConcept C55493867 @default.
• W4285800229 hasConcept C71924100 @default.
• W4285800229 hasConcept C75217442 @default.
• W4285800229 hasConcept C8337478 @default.
• W4285800229 hasConcept C86554907 @default.
• W4285800229 hasConcept C98274493 @default.
• W4285800229 hasConceptScore W4285800229C104317684 @default.
• W4285800229 hasConceptScore W4285800229C126322002 @default.
• W4285800229 hasConceptScore W4285800229C141071460 @default.
• W4285800229 hasConceptScore W4285800229C185592680 @default.
• W4285800229 hasConceptScore W4285800229C190283241 @default.
• W4285800229 hasConceptScore W4285800229C190409667 @default.
• W4285800229 hasConceptScore W4285800229C2776415932 @default.
• W4285800229 hasConceptScore W4285800229C55493867 @default.
• W4285800229 hasConceptScore W4285800229C71924100 @default.
• W4285800229 hasConceptScore W4285800229C75217442 @default.
• W4285800229 hasConceptScore W4285800229C8337478 @default.
• W4285800229 hasConceptScore W4285800229C86554907 @default.
• W4285800229 hasConceptScore W4285800229C98274493 @default.
• W4285800229 hasFunder F4320321001 @default.
• W4285800229 hasLocation W42858002291 @default.
• W4285800229 hasLocation W42858002292 @default.

• next